SCHEMBL8097903

SCHEMBL8097903

CC(Cc1ccc(C#N)cc1)(NC(=O)C1CC(C(=O)O)CN(CCc2ccccc2)C1)c1cnc[nH]1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.38
CHRM4 P08173 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HRH3 Q9Y5N1 2/20 0.35
FNTA P49354 6/20 0.34
FNTB P49356 6/20 0.34
PGGT1B P53609 2/20 0.34
S1PR1 P21453 1/20 0.34
S1PR5 Q9H228 1/20 0.34
HAT1 O14929 2/20 0.34
EP300 Q09472 2/20 0.34
KCNH2 Q12809 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097896 1.00 CYP19A1 (0.38) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8088328 0.96 CYP19A1 (0.38) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8088333 0.96 CYP19A1 (0.38) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8097913 0.94 L3MBTL1 (0.39) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8101712 0.94 CHRM4 (0.39) CYP19A1CHRM4L3MBTL1FNTAFNTB
SCHEMBL8097906 0.94 L3MBTL1 (0.39) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8101707 0.94 CHRM4 (0.39) CYP19A1CHRM4L3MBTL1FNTAFNTB
SCHEMBL8095938 0.93 CHRM4 (0.37) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8095934 0.93 CHRM4 (0.37) CYP19A1CHRM4L3MBTL1HRH3FNTA
SCHEMBL8104371 0.90 CYP19A1 (0.39) CYP19A1CHRM4L3MBTL1HRH3FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127366-A ANTICARCINOGENIC OR ANTITUMOR AGENTS MERCK & CO., INC. (US) 2000-10-03 US disclosed